Ads

 

Ads

 

Ads

 

World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Biotechnology Companies in 2024
Metatag Abstract
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.
  1. RAPT Therapeutics Inc.

    World Rank (Jan-05-2024)
    9,736
    Market Cap (Jan-05-2024)
    0.807 Billion USD
    World Rank (Jul-30-2023)
    9,835
    Market Cap (Jul-30-2023)
    0.812 Billion USD
    World Rank (Dec-25-2022)
    11,440
    Market Cap (Dec-25-2022)
    0.583 Billion USD
    World Rank (Jan-07-2022)
    8,681
    Market Cap (Jan-07-2022)
    1.16 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Operating Income in USD
    -85 Million USD
    Annual Net Income in USD
    -84 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    RAPT Therapeutics is a Clinical Stage Immunology Based Biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. It is having 68 employees as on 2019. The headquarters is in USA.
  2. Icosavax Inc.

    World Rank (Jan-05-2024)
    9,832
    Market Cap (Jan-05-2024)
    0.792 Billion USD
    World Rank (Jul-30-2023)
    14,442
    Market Cap (Jul-30-2023)
    0.380 Billion USD
    World Rank (Dec-25-2022)
    13,274
    Market Cap (Dec-25-2022)
    0.438 Billion USD
    World Rank (Jan-07-2022)
    11,342
    Market Cap (Jan-07-2022)
    0.71 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -66 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  3. Zogenix

    World Rank (Jan-05-2024)
    9,904
    World Rank (Jul-30-2023)
    9,904
    World Rank (Dec-25-2022)
    9,904
    World Rank (Jan-07-2022)
    9,904
    Market Cap (Jan-07-2022)
    0.92 Billion USD
    Annual Revenue in USD
    14 Million USD
    Annual Net Income in USD
    -209 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Zogenix is a Pharmaceutical company. The headquarters is in USA.
  4. Pharming Group

    World Rank (Jan-05-2024)
    9,918
    Market Cap (Jan-05-2024)
    0.781 Billion USD
    World Rank (Jul-30-2023)
    9,830
    Market Cap (Jul-30-2023)
    0.812 Billion USD
    World Rank (Dec-25-2022)
    9,772
    Market Cap (Dec-25-2022)
    0.772 Billion USD
    World Rank (Jan-07-2022)
    12,512
    Market Cap (Jan-07-2022)
    0.58 Billion USD
    Headquarters Country
  5. Editas Medicine

    World Rank (Jan-05-2024)
    9,928
    Market Cap (Jan-05-2024)
    0.779 Billion USD
    World Rank (Jul-30-2023)
    10,632
    Market Cap (Jul-30-2023)
    0.707 Billion USD
    World Rank (Dec-25-2022)
    11,186
    Market Cap (Dec-25-2022)
    0.608 Billion USD
    World Rank (Jan-07-2022)
    6,883
    Market Cap (Jan-07-2022)
    1.72 Billion USD
    Annual Revenue in USD
    20 Million USD
    Annual Operating Income in USD
    -225 Million USD
    Annual Net Income in USD
    -220 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Editas Medicine is a Biotechnology company. It is a genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. The company discover, develop, manufacture, and commercialize transformative, durable and precise genomic medicines for a broad class of diseases. The headquarters is in USA.
  6. Avidity Biosciences Inc.

    World Rank (Jan-05-2024)
    9,931
    Market Cap (Jan-05-2024)
    0.779 Billion USD
    World Rank (Jul-30-2023)
    11,019
    Market Cap (Jul-30-2023)
    0.659 Billion USD
    World Rank (Dec-25-2022)
    6,880
    Market Cap (Dec-25-2022)
    1.389 Billion USD
    World Rank (Jan-07-2022)
    10,012
    Market Cap (Jan-07-2022)
    0.90 Billion USD
    Annual Revenue in USD
    9 Million USD
    Annual Operating Income in USD
    -178 Million USD
    Annual Net Income in USD
    -173 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Avidity Biosciences is a BioTechnology company and pioneer in new class of Oligonucleotide Based Therapies company designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. The company annual revenue is 5.3 million USD and 38 employees as on 2020. The headquarters is in USA.
  7. Revance Therapeutics

    World Rank (Jan-05-2024)
    9,978
    Market Cap (Jan-05-2024)
    0.772 Billion USD
    World Rank (Jul-30-2023)
    5,937
    Market Cap (Jul-30-2023)
    1.893 Billion USD
    World Rank (Dec-25-2022)
    6,247
    Market Cap (Dec-25-2022)
    1.613 Billion USD
    World Rank (Jan-07-2022)
    8,614
    Market Cap (Jan-07-2022)
    1.17 Billion USD
    Annual Revenue in USD
    132 Million USD
    Annual Operating Income in USD
    -272 Million USD
    Annual Net Income in USD
    -356 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Revance Therapeutics is a Biotechnology company. It is focused on innovative aesthetic and therapeutic offerings as well as financial technology services for aesthetic practices. It is having 193 employees as on 2019. The headquarters is in USA.
  8. REGENXBIO Inc.

    World Rank (Jan-05-2024)
    10,026
    Market Cap (Jan-05-2024)
    0.765 Billion USD
    World Rank (Jul-30-2023)
    9,791
    Market Cap (Jul-30-2023)
    0.818 Billion USD
    World Rank (Dec-25-2022)
    8,565
    Market Cap (Dec-25-2022)
    0.963 Billion USD
    World Rank (Jan-07-2022)
    8,285
    Market Cap (Jan-07-2022)
    1.25 Billion USD
    Annual Revenue in USD
    112 Million USD
    Annual Operating Income in USD
    -262 Million USD
    Annual Net Income in USD
    -280 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    REGENXBIO is a Clinical Stage Biotechnology company. The company currently developing gene therapy product candidates for the treatment of retinal, metabolic and neurodegenerative diseases and provide long lasting effects, potentially significantly altering the course of disease and delivering improved patient outcomes. The headquarters is in USA.

Share

Ads